EE200200342A - Substituted 8-arylquinolines, their use, pharmaceutical composition and precursor compound - Google Patents
Substituted 8-arylquinolines, their use, pharmaceutical composition and precursor compoundInfo
- Publication number
- EE200200342A EE200200342A EEP200200342A EEP200200342A EE200200342A EE 200200342 A EE200200342 A EE 200200342A EE P200200342 A EEP200200342 A EE P200200342A EE P200200342 A EEP200200342 A EE P200200342A EE 200200342 A EE200200342 A EE 200200342A
- Authority
- EE
- Estonia
- Prior art keywords
- arylquinolines
- substituted
- pharmaceutical composition
- precursor compound
- precursor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17152299P | 1999-12-22 | 1999-12-22 | |
| PCT/CA2000/001559 WO2001046151A1 (en) | 1999-12-22 | 2000-12-20 | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200200342A true EE200200342A (en) | 2003-06-16 |
Family
ID=22624050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200342A EE200200342A (en) | 1999-12-22 | 2000-12-20 | Substituted 8-arylquinolines, their use, pharmaceutical composition and precursor compound |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP1244628A1 (en) |
| JP (1) | JP3782011B2 (en) |
| KR (1) | KR20020082839A (en) |
| CN (1) | CN1221534C (en) |
| AR (1) | AR029214A1 (en) |
| AU (1) | AU778531B2 (en) |
| BG (1) | BG65403B1 (en) |
| BR (1) | BR0016651A (en) |
| CA (1) | CA2393749C (en) |
| CO (1) | CO5261613A1 (en) |
| CZ (1) | CZ20022171A3 (en) |
| DZ (1) | DZ3244A1 (en) |
| EA (1) | EA004747B1 (en) |
| EE (1) | EE200200342A (en) |
| GE (1) | GEP20053626B (en) |
| HK (1) | HK1057560A1 (en) |
| HR (1) | HRP20020545A2 (en) |
| HU (1) | HUP0203896A3 (en) |
| IL (1) | IL150114A0 (en) |
| IS (1) | IS6413A (en) |
| MX (1) | MXPA02006329A (en) |
| MY (1) | MY134008A (en) |
| NO (1) | NO20023013L (en) |
| NZ (1) | NZ520258A (en) |
| PE (1) | PE20010989A1 (en) |
| PL (1) | PL355752A1 (en) |
| SK (1) | SK8972002A3 (en) |
| TW (1) | TWI280240B (en) |
| UA (1) | UA74815C2 (en) |
| WO (1) | WO2001046151A1 (en) |
| YU (1) | YU47102A (en) |
| ZA (1) | ZA200204862B (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7776315B2 (en) | 2000-10-31 | 2010-08-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and additional active ingredients |
| DE10110772A1 (en) * | 2001-03-07 | 2002-09-12 | Boehringer Ingelheim Pharma | New drug compositions based on anticholinergics and PDE-IV inhibitors |
| WO2002060897A2 (en) | 2000-12-20 | 2002-08-08 | Merck & Co., Inc. | Process for making substituted 8-arylquinolinium benzenesulfonate |
| US6740666B2 (en) * | 2000-12-20 | 2004-05-25 | Merck & Co., Inc. | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| AU2002344885C1 (en) | 2001-06-27 | 2006-11-09 | Merck Frosst Canada Ltd | Substituted 8-arylquinoline PDE4 Inhibitors |
| WO2003010137A1 (en) * | 2001-07-24 | 2003-02-06 | Merck & Co., Inc. | Preparation of sulfonyl quinoline |
| HUP0500078A3 (en) * | 2001-09-19 | 2010-07-28 | Nycomed Gmbh | Pharmaceutical composition containing a combination of a pde inhibitor and a leukotriene receptor antagonist |
| CA2479069A1 (en) * | 2002-03-18 | 2003-09-25 | Merck Frosst Canada & Co./Merck Frosst Canada & Cie | Hetero-bridge substituted 8-arylquinoline pde4 inhibitors |
| MXPA05009434A (en) * | 2003-03-05 | 2005-11-23 | Celgene Corp | Diphenylethylene compounds and uses thereof. |
| EP1732900A4 (en) * | 2004-03-25 | 2007-12-12 | Synta Pharmaceuticals Corp | Acrylonitrile derivatives for inflammation and immune-related uses |
| CA2608158A1 (en) * | 2005-05-19 | 2006-11-23 | Synergenz Bioscience Limited | Methods and compositions for assessment of pulmonary function and disorders |
| ME01901B (en) | 2006-07-05 | 2014-12-20 | Astrazeneca Ab | Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases |
| KR20150004441A (en) * | 2006-07-07 | 2015-01-12 | 칼립시스, 인코포레이티드 | Bicyclic heteroaryl inhibitors of pde4 |
| US20080103105A1 (en) * | 2006-09-22 | 2008-05-01 | Braincells, Inc. | HMG CoA REDUCTASE MEDIATED MODULATION OF NEUROGENESIS |
| US20100204230A1 (en) | 2007-02-12 | 2010-08-12 | Peter Blurton | Piperazine derivatives for treatment of ad and related conditions |
| US8461389B2 (en) | 2008-04-18 | 2013-06-11 | University College Dublin, National University Of Ireland, Dublin | Psycho-pharmaceuticals |
| MX343165B (en) | 2010-02-12 | 2016-10-26 | Raqualia Pharma Inc | 5-ht4 receptor agonists for the treatment of dementia. |
| WO2013024022A1 (en) | 2011-08-12 | 2013-02-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for treatment of pulmonary hypertension |
| WO2013054153A1 (en) | 2011-10-11 | 2013-04-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Nutlin compounds for use in he treatment of pulmonary hypertension |
| AU2018326785B2 (en) * | 2017-09-03 | 2023-03-02 | Angion Biomedica Corp. | Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9226830D0 (en) * | 1992-12-23 | 1993-02-17 | Celltech Ltd | Chemical compounds |
| US5455252A (en) * | 1993-03-31 | 1995-10-03 | Syntex (U.S.A.) Inc. | Optionally substituted 6,8-quinolines |
| US6245774B1 (en) * | 1994-06-21 | 2001-06-12 | Celltech Therapeutics Limited | Tri-substituted phenyl or pyridine derivatives |
| JPH11209350A (en) * | 1998-01-26 | 1999-08-03 | Eisai Co Ltd | Nitrogen-containing heterocyclic derivative and medicine containing the same |
-
2000
- 2000-12-19 MY MYPI20005965A patent/MY134008A/en unknown
- 2000-12-20 CO CO00096650A patent/CO5261613A1/en not_active Application Discontinuation
- 2000-12-20 KR KR1020027008079A patent/KR20020082839A/en not_active Application Discontinuation
- 2000-12-20 HU HU0203896A patent/HUP0203896A3/en unknown
- 2000-12-20 IL IL15011400A patent/IL150114A0/en unknown
- 2000-12-20 CN CNB00818951XA patent/CN1221534C/en not_active Expired - Fee Related
- 2000-12-20 UA UA2002076108A patent/UA74815C2/en unknown
- 2000-12-20 YU YU47102A patent/YU47102A/en unknown
- 2000-12-20 JP JP2001547062A patent/JP3782011B2/en not_active Expired - Fee Related
- 2000-12-20 AU AU23362/01A patent/AU778531B2/en not_active Ceased
- 2000-12-20 EA EA200200702A patent/EA004747B1/en not_active IP Right Cessation
- 2000-12-20 BR BR0016651-0A patent/BR0016651A/en not_active IP Right Cessation
- 2000-12-20 GE GE4903A patent/GEP20053626B/en unknown
- 2000-12-20 WO PCT/CA2000/001559 patent/WO2001046151A1/en active IP Right Grant
- 2000-12-20 PL PL00355752A patent/PL355752A1/en not_active IP Right Cessation
- 2000-12-20 CA CA002393749A patent/CA2393749C/en not_active Expired - Fee Related
- 2000-12-20 NZ NZ520258A patent/NZ520258A/en unknown
- 2000-12-20 SK SK897-2002A patent/SK8972002A3/en not_active Application Discontinuation
- 2000-12-20 MX MXPA02006329A patent/MXPA02006329A/en not_active Application Discontinuation
- 2000-12-20 CZ CZ20022171A patent/CZ20022171A3/en unknown
- 2000-12-20 DZ DZ003244A patent/DZ3244A1/en active
- 2000-12-20 EP EP00986937A patent/EP1244628A1/en not_active Withdrawn
- 2000-12-20 EE EEP200200342A patent/EE200200342A/en unknown
- 2000-12-21 TW TW089127506A patent/TWI280240B/en not_active IP Right Cessation
- 2000-12-21 AR ARP000106867A patent/AR029214A1/en not_active Application Discontinuation
- 2000-12-22 PE PE2000001396A patent/PE20010989A1/en not_active Application Discontinuation
-
2002
- 2002-06-11 IS IS6413A patent/IS6413A/en unknown
- 2002-06-18 ZA ZA200204862A patent/ZA200204862B/en unknown
- 2002-06-19 BG BG106840A patent/BG65403B1/en unknown
- 2002-06-21 HR HR20020545A patent/HRP20020545A2/en not_active Application Discontinuation
- 2002-06-21 NO NO20023013A patent/NO20023013L/en unknown
-
2004
- 2004-01-26 HK HK04100511A patent/HK1057560A1/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200000468A (en) | The compounds, their use and the pharmaceutical composition | |
| EE200200342A (en) | Substituted 8-arylquinolines, their use, pharmaceutical composition and precursor compound | |
| EE200100391A (en) | Peptidyl-heterocyclic ketones, their use and pharmaceutical composition | |
| EE04464B1 (en) | Indalyl-substituted benzenecarboxamides, process for their preparation, use and pharmaceutical compositions | |
| NO20015175L (en) | Pharmaceutical composition | |
| FI991485A (en) | New pharmaceutical composition | |
| EE200100594A (en) | Novel pharmaceutical compositions based on anticholinergic compounds and β-mimetics | |
| EE200200487A (en) | Azetidine derivatives, processes for their preparation and pharmaceutical composition | |
| EE200200175A (en) | Substituted 2-Thio-3,5-Dicyano-4-aryl-6-aminopyridines and their Uses | |
| EE05183B1 (en) | Azabitic compounds, their preparation and use as pharmaceuticals, and the pharmaceutical composition containing them | |
| TR200003788A3 (en) | Yavas release oral dosage composition. | |
| EE200200064A (en) | Arylmethylcarbonylaminothiazole derivatives, their preparation and their use as anticancer agents | |
| DK1204410T3 (en) | PHARMACEUTICAL DOSAGE FORM WITH MULTIPLE COMPONENTS | |
| ID27415A (en) | PHARMACEUTICAL COMPOSITION | |
| EE200200149A (en) | Quinazoline compounds and pharmaceutical compositions containing them | |
| TR200003787A3 (en) | Stable slow-release oral dosage composition. | |
| EE200300327A (en) | Urea derivatives, processes for their preparation, use and pharmaceutical composition | |
| EE200100009A (en) | Benzimidazoles, their preparation and use as medicaments | |
| EE04275B1 (en) | Quinoline derivatives, processes for their preparation, use and pharmaceutical compositions | |
| EE200000621A (en) | Anti-picornaviral compounds, their preparation and use | |
| ID29149A (en) | ADJUVAN COMPOSITION | |
| ID29262A (en) | PHARMACEUTICAL COMPOSITION | |
| EE200100470A (en) | Pyridopyranoazepine derivatives, their preparation and therapeutic use | |
| EE200100653A (en) | Indolylpiperidine Compounds, Method of Preparation, Composition and Use thereof | |
| ID27201A (en) | PHARMACEUTICAL COMPOSITION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HB1A | Correction of owner name or address | ||
| GB1A | Change in the ownership or in the address of the owner |